Insights on patents, trademarks, and design protection
A patent attorney compares PCT national phase entry and Paris-route direct filing in Korea: 31-month deadline, translation costs, KIPO fee reductions, examination.
Tracking the DABUS case across Korea, the US, EU, UK, Australia, and South Africa — and what the natural-person rule means in practice for AI-assisted inventions in Korea.
Walk through the five-stage PCT timeline, 30/31-month national-phase deadlines, international search and preliminary exam, and the official fees from KIPO as a Receiving Office.
Compare the term, inventive-step bar, and filing fees of Korean patents vs. utility models, with practical guidance on which to choose for your invention.
Korean priority examination cuts pendency from 14.7 to 2.1 months on average. A practitioner's guide to grounds, fees, PPH, and the one-month super-fast track.
How to run a Freedom-to-Operate analysis before launching in Korea, design around problem patents, and account for the doctrine of equivalents.
Korean patent prosecution runs through five stages — filing, publication, examination request, substantive review, and registration. A practitioner's guide to deadlines, fees, expedited options, and reductions.
Article 52 of the Korean Patent Act sets three windows for divisional filings. We cover the timing, the unity requirement, and four practical filing strategies.
App and platform patents are tricky because algorithms are inherently functional. We compare functional and structural claims under KIPO and US §112(f) means-plus-function rules.
How to lock in a Korean filing date with PPT, PDF, or research notes only: the 14-month completion deadline, traps, and how it differs from US provisional applications.
A cosmetic is rarely protected by one right alone. We map KIPO formulation patents, design registrations, trade dress, and MFDS functional cosmetic review into one strategy.
Medical-device IP is uniquely entangled with regulatory clearance. We map Korean MFDS device grades against KIPO patents, FDA 510(k)/PMA pathways, and a synchronized filing strategy.
What to do when KIPO issues a Patent-Act Article 63 office action — types of rejection, amendment vs. argument, deadline management, and the final-OA path.